A Japanese-American woman with advanced Alzheimer’s disease showed noticeable improvements after she took a high dose of magic mushrooms in a case study.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.
As someone educated in statistics, I have a pretty good idea about what you can learn from a sample size of one. It’s about as close to nothing as you can get without it quite being nothing.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
Anyway, with that said, here’s a link to the case study since CTV’s seems to be malformatted.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.
As someone educated in statistics, I have a pretty good idea about what you can learn from a sample size of one. It’s about as close to nothing as you can get without it quite being nothing.